top of page
Ancla 1
A.jpg

 Our Platform

 Two different lung-specific bacterial chassis (MycoChassis and LactoChassis), designed to treat acute and chronic respiratory diseases, respectively. These chassis are able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner.

Pulmoproteinas.png

 IMMUNE SYSTEM MODULATION

LC_08.png

 Lung Cancer

Immune stimulatory interleukins, nanobodies against immune check point inhibitors

LC_02.png

 Asthma

Modified interleukins

nanobodies

LC_03.png

 Pulmonary alveolar proteinosis

GM-CSF mutants

 ANTIMICROBIAL AND BIOFILM DISPERSION

ACUTE

LC_03.png

 Cystic Fibrosis

 Infectious diseases

Antibacterial and

biofilm-dispersing agents

LC_09.png

 VAP

 Infectious diseases

Antibacterial and

biofilm-dispersing agents

 PROTEIN SUPPLEMENTATION

FOR GENETIC DISEASES

LC_05.png

 Chronic obstructive

Pulmonary disease

A1AT

LC_06.png

 Interstitial lung disease

Surfactant proteins

bottom of page